Acadia Healthcare Company, Inc.
ACHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.73 | 0.06 | -1.11 | -0.54 |
| FCF Yield | -2.82% | -1.67% | -5.87% | -2.39% |
| EV / EBITDA | 36.65 | 32.09 | 55.27 | 52.48 |
| Quality | ||||
| ROIC | 1.93% | 1.85% | 0.16% | 1.66% |
| Gross Margin | 96.43% | 96.72% | 32.60% | 96.31% |
| Cash Conversion Ratio | 1.91 | 3.52 | 1.27 | 3.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.50% | 5.15% | 5.37% | 6.51% |
| Free Cash Flow Growth | -84.06% | 79.01% | -87.98% | -220.15% |
| Safety | ||||
| Net Debt / EBITDA | 18.61 | 16.81 | 24.65 | 18.67 |
| Interest Coverage | 3.26 | 4.05 | 0.46 | 3.44 |
| Efficiency | ||||
| Inventory Turnover | 4.87 | 4.90 | 90.95 | 5.05 |
| Cash Conversion Cycle | -460.87 | -625.02 | 20.30 | -666.44 |